RMD: Volume-driven growth, tech innovation, and GLP-1s fuel strong performance and expanding margins
Guidance was provided for 5%-7% revenue growth, with strong volume-driven performance and expanding margins. Strategic acquisitions, tech partnerships, and AI-driven patient engagement are enhancing adherence and supporting growth. GLP-1s are now a growth tailwind, and portfolio management includes…